RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation* (Micro-RayStation), a software platform for planning and evaluation in small animal irradiation research; RayPlan, a treatment planning system; DrugLog, which verifies the identity and concentration of compounded injectables before administered to a patient; RayMigrate, allows users to convert Pinnacle patient data to RayStation format and/or to DICOM format; Machine Learning; and Liver Ablation Solutions. The company was founded in 2000 and is headquartered in Stockholm, Sweden.
Frequently asked questions
What sector does RaySearch Laboratories AB (publ) (RAY-B) operate in?
RaySearch Laboratories AB (publ) belongs to the Healthcare sector and operates in the Health Information Services industry.
What is RaySearch Laboratories AB (publ) (RAY-B) current stock price?
As of the latest data, RaySearch Laboratories AB (publ) stock price is SEK 188.20, with a previous close of SEK 190.70. RaySearch Laboratories AB (publ) lost -SEK 2.50 in the last trading session, representing a -1.31% loss.
What is RaySearch Laboratories AB (publ) (RAY-B) current market capitalization?
RaySearch Laboratories AB (publ) market cap is approximately 5.72 billion.
What is RaySearch Laboratories AB (publ) (RAY-B) Earnings Per Share (EPS)?
The trailing EPS is SEK 6.54, and the forward EPS is SEK 9.35.
What is RaySearch Laboratories AB (publ) (RAY-B) Price-to-Earnings (P/E) ratio?
RaySearch Laboratories AB (publ) current P/E ratio is 28.78, with a forward P/E of 20.13.
What is RaySearch Laboratories AB (publ) (RAY-B) EBITDA?
RaySearch Laboratories AB (publ) EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 122.90 million.
Does RaySearch Laboratories AB (publ) (RAY-B) pay dividends?
Yes. RaySearch Laboratories AB (publ) pays annual dividends with an annualized yield of 2.13% and an estimated annual payout of SEK 4.00 per share.
When is the next ex-dividend date for RaySearch Laboratories AB (publ) (RAY-B)?
The next ex-dividend date is scheduled for May 08, 2027.
When is RaySearch Laboratories AB (publ) (RAY-B) next earnings report?
RaySearch Laboratories AB (publ) is expected to release its next earnings report on June 30, 2026.
What is RaySearch Laboratories AB (publ) (RAY-B) beta (volatility) score?
RaySearch Laboratories AB (publ) has a beta of 0.932, meaning its volatility is roughly in line with the market.
